ETV6-RUNX1 accounts for ~25% of pediatric B-ALL cases and is detected in 1–5% of all newborns, as demonstrated by studies of neonatal blood spots and PCR of ligated breakpoints4,5. Here, ETV6 is linked to precursor B-cell acute lymphoblastic leukemia.